p38α MAPK inhibits JNK activation and collaborates with IκB kinase 2 to prevent endotoxin‐induced liver failure
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Activation of c‐Jun amino‐terminal kinase (JNK) facilitates tumour necrosis factor (TNF)‐induced cell death. The p38 mitogen‐activated protein kinase pathway is induced by TNF stimulation, but it has not been implicated in TNF‐induced cell death. Here, we show that hepatocyte‐specific ablation of p38α in mice results in excessive activation of JNK in the liver after in vivo challenge with bacterial lipopolysaccharide (LPS). Despite increased JNK activity, p38α‐deficient hepatocytes were not sensitive to LPS/TNF toxicity showing that JNK activation was not sufficient to mediate TNF‐induced liver damage. By contrast, LPS injection caused liver failure in mice lacking both p38α and IκB kinase 2 (IKK2) in hepatocytes. Therefore, when combined with partial nuclear factor‐κB inhibition, p38α deficiency sensitizes the liver to cytokine‐induced damage. Collectively, these results reveal a new function of p38α in collaborating with IKK2 to protect the liver from LPS/TNF‐induced failure by controlling JNK activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., & Mak, T. W. (1993) · Cell · doi:10.1016/0092-8674(93)90134-c · Cited by 1,677 · cited 2×
“After in vivo administration of lipopolysaccharide (LPS), which acts as a potent inducer of endogenous TNF and other cytokines that can cause liver damage”
BackgroundIndependent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms
Dérijard, B., Raingeaud, J., Barrett, T., Wu, I.-H., Han, J., Ulevitch, R. J., & Davis, R. J. (1995) · Science · doi:10.1126/science.7839144 · Cited by 1,555 · cited 2×
“Two upstream kinases control phosphorylation of JNK, of which MAP kinase kinase (MKK)7 specifically acts on JNK, and is activated by TNF and environmental stress, whereas MKK4 can phosphorylate both JNK and p38 MAPK, and is normally not activated by TNF”
BackgroundChang, L., Kamata, H., Solinas, G., Luo, J.-L., Maeda, S., Venuprasad, K., Liu, Y.-C., & Karin, M. (2006) · Cell · doi:10.1016/j.cell.2006.01.021 · Cited by 706 · cited 4×
“Sustained c-Jun amino-terminal kinase ( JNK) activation is important for TNF-induced killing of NF-kB-deficient cells, by acting through the ubiquitin ligase ITCH to induce proteasome-dependent degradation of cellular FLICE inhibitory protein (c-FLIP; Chang et al, 2006).”
BackgroundInfluential
Cited by
Signal integration by JNK and p38 MAPK pathways in cancer development
Wagner, E. F., & Nebreda, Á. R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2694 · Cited by 2,586
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma
Luedde, T., & Schwabe, R. F. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.213 · Cited by 1,345
“Conditional deletion of p38α, the main p38 isoform, results in excessive JNK activation in response to LPS injection via hyperactivation of the upstream MAPK kinases MEKK4 and MEKK7”
BackgroundSelf-citationThe p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer
Yong, H.-Y., Koh, M.-S., & Moon, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903321490 · Cited by 422
“Several groups have reported that p38 MAPK inhibition induced activation of JNK in many human cell types [135-137].”
BackgroundTargeting innate immunity protein kinase signalling in inflammation
Gaestel, M., Kotlyarov, A., & Kracht, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2829 · Cited by 316
Bonnet, M. C., Preukschat, D., Welz, P.-S., van Loo, G., Ermolaeva, M. A., Bloch, W., Haase, I., & Pasparakis, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.014 · Cited by 295
Self-citation
Metadata
- Authors
- Heinrichsdorff, J., Luedde, T., Perdiguero, E., Nebreda, A. R., & Pasparakis, M.
- Venue
- EMBO reports
- Published
- 2008-08-15
- Volume
- 9
- Issue
- 10
- Pages
- 1048-1054
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- OpenAlex
- W2097120271
- Cited by
- 99
- References
- 5
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.